Krishnamurthy, Ramkumar

Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes

Sathyanarayana, P., Jogi, M., Muthupillai, R., Krishnamurthy, R., Samson, S. L., & Bajaj, M. (2011) · Obesity

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 124

Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial

Samson, S. L., Sathyanarayana, P., Jogi, M., Gonzalez, E. V., Gutierrez, A., Krishnamurthy, R., Muthupillai, R., Chan, L., & Bajaj, M. (2011) · Diabetologia

Fibroblast Growth Factor ResearchLiver Disease Diagnosis and Treatment

Cited by 110

Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood: Mother's BMI and childhood metabolic risk

Tan, H. C., Roberts, J., Catov, J., Krishnamurthy, R., Shypailo, R., & Bacha, F. (2015) · Pediatric Diabetes

Birth, Development, and HealthGestational Diabetes Research and Management

Cited by 76